Fulyzaq Development Timeline
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
A chronology of events leading to the approval of Salix Pharmaceuticals’ crofelemer for antiretroviral therapy-associated diarrhea in HIV patients.